Commodore Capital
New York City, New Yorkcommodorecapital.com
Overview
Commodore Capital is an investment management firm that serves as an investment advisor with discretionary trading authority to private, pooled investment vehicles. The firm may employ various long/short investment strategies, which depend on the ability to identify and purchase undervalued investments and sell short overvalued investments . The firm specializes in venture capital investments within the healthcare sector, leveraging a science-driven approach .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AN2 Therapeutics | Mar 2026 | Follow-on Offering | Co-investor |
| Galecto Biotech | Nov 2025 | Private Placement | Co-investor |
| Neurogene | Nov 2024 | PIPE | Co-investor |
| IDRx | Aug 2024 | Series B | Lead |
| Enliven Therapeutics | Mar 2024 | Private Placement | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.